Articles

Perceived accessibility and mental health consequences of COVID-19 containment policies

Elsevier,

Journal of Transport and Health, Volume 25, June 2022

The article looks at the effects on mental health when accessibility was limited during COVID-19 containment policies.
Read more

SDG:

Goal 3: Good health and well-being

Tags:

Health and wellbeing, Global

A comparison between healthcare workers and non-healthcare workers’ anxiety, depression and PTSD during the initial COVID -19 lockdown

Elsevier,

Public Health in Practice, Volume 3, June 2022

Content examines the health and wellbeing of healthcare assistants vs non-healthcare assistants during the COVID-19 pandemic. Ties with goal on educating all about mental health and working towards health and wellbeing for all.
Read more

SDG:

Goal 3: Good health and well-being; Goal 4: Quality education

Tags:

Health and wellbeing, Europe

Depression in Sub-Saharan Africa

Elsevier,

IBRO Neuroscience Reports, Volume 12, June 2022

This review attempts to shed more light on the prevalence of depression in Sub-Saharan Africa (SSA), its pathophysiology, risk factors, diagnosis and the experimental models available to study depression within the sub-region. It also evaluates the contribution of the sub-region to the global research output of depression as well as bottlenecks associated with full exploitation of the sub region’s resources to manage the disorder.
Read more

SDG:

Goal 10: Reduced inequalities

Tags:

Health and wellbeing, Africa

Investigating the effect of Mindfulness-Based Stress Reduction on stress level and brain activity of college students

Elsevier,

IBRO Neuroscience Reports, Volume 12, June 2022

Financial constraints usually hinder students, especially those in low-middle income countries (LMICs), from seeking mental health interventions. Hence, it is necessary to identify effective, affordable and sustainable counter-stress measures for college students in the LMICs context. This study examines the sustained effects of mindfulness practice on the psychological outcomes and brain activity of students.
Read more

SDG:

Goal 3: Good health and well-being; Goal 10: Reduced inequalities

Tags:

Health and wellbeing, Global

Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases

Elsevier,

Heliyon, Volume 8, June 2022

This review highlights the role of liposomes in delivering drugs across blood-brain barrier which has been seen to reducing the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD).
Read more

SDG:

Goal 3: Good health and well-being

Tags:

Health and population; Health and wellbeing; Science, Global

Covid-19 vaccine immunogenicity in people living with HIV-1

Immunogenicity in each study group. Immunogenicity (anti-RBD IgG response) was measured by ELISA and reported in RLU (relative luminescence units) normalized to CR3022.
Elsevier,

Vaccine, Volume 40, 9 June 2022

COVID-19 vaccine efficacy has been evaluated in large clinical trials and in real-world situation. Although they have proven to be very effective in the general population, little is known about their efficacy in immunocompromised patients.
Read more

SDG:

Goal 3: Good health and well-being; Goal 10: Reduced inequalities

Kaposi's sarcoma-associated herpes virus-derived microRNA K12–1 over-activates the PI3K/Akt pathway to facilitate cancer progression in HIV-related gastrointestinal Kaposi's sarcoma

Elsevier,

SLAS Discovery, Volume 27, June 2022

Understanding the pathogenesis that leads to carcinogenesis of HIV-related gastrointestinal KS is essential for the treatment of diseases related to KSHV infection. This study strived to evaluate the effect of miR-K12–1 on the progression of HIV-related gastrointestinal KS.
Read more

SDG:

Goal 3: Good health and well-being
Global

HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect

Elsevier,

Antiviral Research, Volume 202, June 2022

Nelfinavir is an HIV protease inhibitor that has been widely prescribed as a component of highly active antiretroviral therapy, and has been reported to exert in vitro antiviral activity against SARS-CoV-2. We here assessed the effect of Nelfinavir in a SARS-CoV-2 infection model in hamsters. 
Read more

SDG:

Goal 3: Good health and well-being; Goal 10: Reduced inequalities
Global

Provider preferences for anal cancer prevention screening: Results of the International Anal Neoplasia Society survey

Elsevier,

Tumour Virus Research, Volume 13, June 2022

This study explores provider preferences regarding anal cancer screening indications, initiation age, tools, and referral threshold to high resolution anoscopy (HRA). Although consensus was lacking with regard to specific screening initiation age, more respondents recommended younger initiation ages for men who have sex with men (MSM) living with HIV (LWH) compared with MSM not LWH (p
Read more

SDG:

Goal 3: Good health and well-being; Goal 10: Reduced inequalities
Global

Oral human papillomavirus prevalence, persistence, and risk-factors in HIV-positive and HIV-negative adults

Alluvial plots denote transitions in oral HPV infection status (any genotype) over the first four study visits in a) HIV+ and b) HIV- participants who had at least 2 valid HPV tests before loss to follow up or completion of 4th visit.
Elsevier,

Tumour Virus Research, Volume 13, June 2022

HIV has been shown to increase the likelihood of oral HPV infection. In this study, we evaluated the risk of oral HPV in HIV infected patients compared with HIV-negative controls.
Read more

SDG:

Goal 3: Good health and well-being; Goal 10: Reduced inequalities

Tags:

HIV, Global

Pages